Kenneth Londoner is the founder of BioSig Technologies, a medical device company. He also serves as its CEO and Chairman. This company has developed the PURE EP System. This system aims to provide more accurate treatment to patients suffering from Atrial Fibrillation and Complex Arrhythmia. Kenneth Londoner has over three decades long experience which encompasses general management and marketing. He dedicated to assisting a number of emerging growth companies in their corporate development and investing needs. Londoner holds a Bachelor’s Degree in economics and finance from the Lafayette College in Easton, Pennsylvania. He graduated from this college in 1989. Moreover, Londoner received his MBA from NYU’s Stern School of Business with a dual major in finance and management in 1994. Kenneth Londoner also co-founded the company Safe Ports Holdings was a Member of its Board of Directors. Soon, he became the youngest money manager to ever manage the Safeports Growth Fund and the Capital Fund. From April 2007 to October 2009, Kenneth Londoner served as an Executive Vice President of Finance and Consultant at NewCardio. This is a cardiac software company based in the Silicon Valley.